PHARMACOLOGICAL DIFFERENCES BETWEEN R(-)-IBUPROFEN AND S(+)-IBUPROFEN

被引:56
作者
GEISSLINGER, G
STOCK, KP
BACH, GL
LOEW, D
BRUNE, K
机构
[1] KLIN HERZOGHOHE,D-8580 BAYREUTH,FED REP GER
[2] MEDICE PHARMACEUT,D-5860 ISERLOHN,FED REP GER
来源
AGENTS AND ACTIONS | 1989年 / 27卷 / 3-4期
关键词
D O I
10.1007/BF01972851
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:455 / 457
页数:3
相关论文
共 6 条
[1]   PHARMACOLOGICAL DIFFERENCES BETWEEN OPTICAL ISOMERS OF IBUPROFEN - EVIDENCE FOR METABOLIC INVERSION OF (-)-ISOMER [J].
ADAMS, SS ;
BRESLOFF, P ;
MASON, CG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (03) :256-257
[2]   INHIBITION BY ANTI-INFLAMMATORY DRUGS OF PROSTAGLANDIN PRODUCTION IN CULTURED MACROPHAGES - FACTORS INFLUENCING THE APPARENT DRUG EFFECTS [J].
BRUNE, K ;
RAINSFORD, KD ;
WAGNER, K ;
PESKAR, BA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 315 (03) :269-&
[3]   PHARMACOLOGICAL CONTROL OF LEUKOTRIENE AND PROSTAGLANDIN PRODUCTION FROM MOUSE PERITONEAL-MACROPHAGES [J].
BRUNE, K ;
AEHRINGHAUS, U ;
PESKAR, BA .
AGENTS AND ACTIONS, 1984, 14 (5-6) :729-734
[4]  
GEISSLINGER G, 1989, IN PRESS J CHROMATO
[5]  
HEINZEL G, 1982, DRUG DEV EVALUATION, V6
[6]  
JENNER P, 1974, DRUG METAB REV, V2, P117